OptoSeeker Awarded Shenzhen Major Science and Technology Grant
Shenzhen, June 13, 2025 – OptoSeeker, a pioneer in optoelectronic microfluidic solutions, today announced it has been selected to receive funding from the Shenzhen Major Science and Technology Special Fund. The award recognizes OptoSeeker’s innovative applications of Optoelectronic Tweezer (OET) technology in the life sciences and places the company among a select group of enterprises and research institutions across the region.
About the Award
The Shenzhen Major Science and Technology Special Fund supports critical core technologies, key components, and major equipment projects that enhance industrial competitiveness and foster independent innovation. This initiative is central to Shenzhen’s strategy of building a high‑tech ecosystem and accelerating the city’s drive toward technological self‑reliance.
OptoSeeker’s Achievement
Since its founding in September 2023, OptoSeeker has focused on cutting‑edge areas such as biopharmaceuticals, cell and gene therapy, and synthetic biology. Leveraging its proprietary OET platform, the company has developed advanced tools for precise single‑cell manipulation and analysis. The grant underscores:
-
Research Excellence: Demonstrated ability to overcome key challenges in high‑end life science instrumentation.
-
Innovation Leadership: Validation of OptoSeeker’s disruptive approach to intelligent cell screening and microfluidic control.
-
Local Impact: Strong endorsement by Shenzhen authorities of the company’s potential to drive high‑quality growth in the regional biotech sector.
Next Steps
With funding in place, OptoSeeker will:
-
Scale R&D – Expand efforts to refine and extend OET-based platforms into new application areas.
-
Secure IP – Advance the company’s portfolio of patents and proprietary technologies.
-
Commercialize Solutions – Accelerate product development and market introduction, leveraging Shenzhen’s robust innovation environment.
